期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

中西医结合治疗特发性血小板减少性紫癜概况及评析 被引量：3

Combination of TCM and WM Treat Idiopathic Thrombacytopenic Purpura
暂未订购
导出
摘要 特发性血小板减少性紫癜是临床常见的一种出血性疾病,在临床上应用中医中药结合西医激素等治疗取得了比较确切的疗效,就近3年来中西医结合特发性血小板减少性紫癜的概况进行了综述及评析。 Idiopathic thrombacytopenic purpura is a kind of common bleeding disease clinically, which gets definite effect treated with TCM combined with hormone in western medicine（WM）. It makes summary and analysis on the disease treated with combination of TCM and WM for recent 3 years.
作者 李珍 沈一平 周郁鸿
机构地区 浙江中医药大学附属第一医院
出处 《浙江中医药大学学报》 CAS 2007年第2期245-246,共2页 Journal of Zhejiang Chinese Medical University
关键词 特发性血小板减少性紫癜 中西医结合疗法 评析 idiopathic thrombacytopenic purpura therapy of combination of TCM and WM analysis
分类号 R554.6 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献11

二级参考文献28

  • 1中华医学会血液学学会血栓与止血学组.几种出血性疾病诊断（及疗效）标准的修订[J].中华血液学杂志,1995,16:331-331.
  • 2[3]Berchtold P. Therapy of chronic idiopathic thrombcytopenic purpura in adults[J]. Blood, 1989,74(7) :2 039.
  • 3[4]Giagounidis AAN, Anhuf J, Schneider P, et al. Treatment of relapsed idiopathic thrombocytopenic purpura with the antiCD20 monoclonal antibody rituximab: a pilot study [J]. Eur J Haematol, 2002, 69:95.
  • 4戴慎 薛建国 岳沛群.中医病证诊断标准与方及选用(第一版)[M].北京:人民卫生出版社,2001.110-113.
  • 5Kuwana M, Kawakami Y, lkeda Y. Suppression of autoreactive T-cell response to glycoprotein Ⅱb/Ⅲ a by blockade of CD40/CD154 interaction:implications for treatmem of immune thrombocytopenic purpura, Blood,2003,101:621-623.
  • 6Boshkov LK, Kehon JG, Halloran PF. HLA-DR expression by platelets in acute idiopathic thrombocytopenic purpura. Br J Haenmtol, 1992, 81:552-557.
  • 7Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic antoinrnune thrombocytopenic purpura: relationship to platele! phenotype and antiplatelet T-cell reactivity. Blood,1996, 87:4245-4254.
  • 8Erduran E, Asian Y, Aliyazicioglu Y, et al. Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura. Am J Hematol, 1998,57:219-223.
  • 9Karakantza M, Mouzaki A, Theodoropoulou M, et al. Thl and Th2 cytokines in a patient with Evans' syndrome and profound lymphopenia. Br J Haematol,2000 110:968-970.
  • 10Yoshimura C, Nomura S, Nagahama M, et al. Plasma-soluble Fas(APO-1, CD95) and soluble Fas ligaald in ilramme thrombocytopenic purpura. Eur J Haematol,2000, 64:219-224.

共引文献53

同被引文献24

  • 1刘凌,冯莹,庞缨,叶絮,蔡晓东,谭获.升血小板胶囊治疗特发性血小板减少性紫癜的疗效观察[J].中国医院用药评价与分析,2004,4(4):233-235. 被引量：7
  • 2陈小林,赖应昌,冯秀娟,陈万宁,祁妙华,姜义荣,刘扶兴.大剂量地塞米松治疗慢性特发性血小板减少性紫癜的临床研究[J].临床血液学杂志,2007,20(1):46-47. 被引量：14
  • 3梁金秋,尹薇.升血小板胶囊配合激素治疗特发性血小板减少性紫癜40例[J].中国医药导报,2007,4(07S):54-55. 被引量：1
  • 4Rodeghiero F, Stasi R, Gernsheimer T, el al. Standardization of ter- minology, definitions and outcome criteria in immune thrombocy- topenic purpura of adults and children: report from an internat/onal working group. Blood, 2009, 113(11): 2386 -2393.
  • 5Stasi R, Evangelista ML, Stipa E, et al. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost, 2008, 99(1): 4-13. PMID: 18217129.
  • 6Higgins PT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
  • 7Zen M, Canova M, Campana C, et al. "Ihe kaleidoscope of glucorti- coid effects on immune system. Autoimmun Rev, 2011, 10(6): 305- 310.
  • 8国家中医药管理局老中医药专家学术经验继承办公室.方药传真.南京:江苏科学技术出版社,2003:56.
  • 9姚庆民,候明.大剂量地塞米松冲击升血小板胶囊维持治疗特发性血小板减少性紫癜.山东大学硕士学位论文,2006.
  • 10张之南.血液病诊断及疗效标准[M]北京:北京科学技术出版社,1998279-284.

引证文献3

二级引证文献24

浙江中医药大学学报
2007年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部